Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Coeptis Therapeutics Holdings (COEP) Gross Profit (2025)

Historic Gross Profit for Coeptis Therapeutics Holdings (COEP) over the last 1 years, with Q3 2025 value amounting to $192286.0.

  • Coeptis Therapeutics Holdings' Gross Profit changed N/A to $192286.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $365528.0, marking a year-over-year change of. This contributed to the annual value of $75000.0 for FY2021, which is N/A changed from last year.
  • As of Q3 2025, Coeptis Therapeutics Holdings' Gross Profit stood at $192286.0.
  • Coeptis Therapeutics Holdings' Gross Profit's 5-year high stood at $192286.0 during Q3 2025, with a 5-year trough of $17718.0 in Q1 2025.